Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01478594
What this trial is testing

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy

Who this might be right for
Colorectal Cancer
AVEO Pharmaceuticals, Inc. 265
Not applicableStudy completedNCT01399190
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)Study completedNCT03439462
What this trial is testing

Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Aadi Bioscience, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT04247984
What this trial is testing

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Chinese Academy of Medical Sciences 264
Not applicableUnknownNCT04684095
What this trial is testing

The Effect of ePRO on Quality of Life and Prognosis of Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticCancer
Harbin Medical University 338
Testing effectiveness (Phase 2)UnknownNCT03940131
What this trial is testing

Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR

Who this might be right for
Metastatic Colorectal Cancer
King Abdullah Medical City 30
Testing effectiveness (Phase 2)UnknownNCT04733963
What this trial is testing

Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 112
Testing effectiveness (Phase 2)Study completedNCT02271464
What this trial is testing

Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana 232
Not applicableUnknownNCT01531621
What this trial is testing

A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland

Who this might be right for
Metastatic Colorectal Cancer
Pia Osterlund 1,000
Testing effectiveness (Phase 2)Study completedNCT00125034
What this trial is testing

Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Neoplasm MetastasisColorectal Cancer
Merck KGaA, Darmstadt, Germany 344
Testing effectiveness (Phase 2)Looking for participantsNCT06282445
What this trial is testing

Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 36
Testing effectiveness (Phase 2)Study completedNCT05004441
What this trial is testing

Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Zhou Fuxiang 43
Not applicableEnded earlyNCT02597075
What this trial is testing

Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy

Who this might be right for
Metastatic Colorectal Cancer
Swiss Cancer Institute 100
Early research (Phase 1)UnknownNCT06225622
What this trial is testing

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital 78
Testing effectiveness (Phase 2)Study completedNCT00079872
What this trial is testing

Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 120
Testing effectiveness (Phase 2)Study completedNCT03530267
What this trial is testing

Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer

Who this might be right for
Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 124
Testing effectiveness (Phase 2)Study completedNCT05775900
What this trial is testing

Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 24
Testing effectiveness (Phase 2)Study completedNCT00819780
What this trial is testing

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+1 more
Amgen 285
Not applicableUnknownNCT03286738
What this trial is testing

Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Joong Bae Ahn 1,800
Testing effectiveness (Phase 2)Study completedNCT00689624
What this trial is testing

Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital of Crete 30
Next Page